Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 628

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 628
---
 held by Mr. Bartoszek, (ii) 2,001 shares of common stock held by his children, (iii) 1,748,473 shares of common stock held by RLB Holdings Connecticut LLC for which Mr. Bartoszek has shared 
 voting rights and dispositive power and (iv) 41,827 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of May 15, 2025.                                                   |

| (7) | Consists of (i) 675,230 shares of common stock held by Dr. Iadonato, (ii) 8,553 shares of common stock                                                                                        
 held in a custodial individual retirement account and (iii) 338,694 shares of common stock issuable upon exercise of outstanding options that are exercisable within 60 days of May 15, 2025. |

| (8) | Consists of (i) 143,204 shares of common stock, (ii) 41,827 shares of common stock issuable upon exercise of                                                                                   
 outstanding options that are exercisable within 60 days of May 15, 2025 and (iii) 14,350 shares that may be acquired pursuant to warrants that are exercisable within 60 days of May 15, 2025. |

| (9) | Consists of (i) 88,097 shares of common stock and (ii) 36,875 shares of common stock issuable upon exercise of 
 outstanding options that are exercisable within 60 days of May 15, 2025.                                       |

| (10) | Consists of (i) 2,777 shares of common stock and (ii) 36,875 shares of common stock issuable upon exercise of 
 outstanding options that are exercisable within 60 days of May 15, 2025.                                      |

| (11) | Consists of (i) 4,000 shares of common stock and (ii) 21,042 shares of common stock issuable upon exercise of 
 outstanding options that are exercisable within 60 days of May 15, 2025.                                      |

| (12) | Consists of 21,042 shares of common stock issuable upon exercise of outstanding options that are exercisable 
 within 60 days of May 15, 2025.                                                                              |

420

INTERESTS OF KINETA’S DIRECTORS AND EXECUTIVE OFFICERS IN THE